<DOC>
	<DOCNO>NCT01621191</DOCNO>
	<brief_summary>The purpose study assess safety efficacy duloxetine participant fibromyalgia long-term use .</brief_summary>
	<brief_title>An Extension Study Duloxetine Fibromyalgia ( Extension F1J-JE-HMGZ , NCT01552057 )</brief_title>
	<detailed_description />
	<mesh_term>Fibromyalgia</mesh_term>
	<mesh_term>Myofascial Pain Syndromes</mesh_term>
	<mesh_term>Duloxetine Hydrochloride</mesh_term>
	<criteria>Participants complete 15week treatment precede study HMGZ Participants wish continuous treatment duloxetine precede study Participants able give write consent Participants serious cardiovascular , hepatic , renal , respiratory , hematological disease , clinically significant laboratory electrocardiogram abnormality indicate serious medical problem require significant intervention judgment investigator Participants alanine aminotransferase/aspartate aminotransferase le 100 International Units/Liter ( IU/L ) total bilirubin le 1.6 milligrams/deciliter ( mg/dL ) Week 0 ( Visit 8 precede study ) Participants serum creatinine level less 2.0 mg/dL , participant undergone kidney transplantation hemodialysis Week 0 ( Visit 8 precede study ) Participants pain difficult discriminate pain associate fibromyalgia disease disturb assessment Participants thyroidal dysfunction , exclude assess investigator disorder control appropriate threemonth long drug therapy Participants present past history rheumatoid arthritis , inflammatory arthritis , infectious arthritis , auto immune disease rather thyroid deficiency Participants uncontrolled angle closure glaucoma Participants receive monoamine oxidase ( MAO ) inhibitor within 14 day Week 0 ( Visit 8 precede study ) need receive MAO inhibitor within 5 day study discontinuation Participants experience suicidal ideation suicide attempt precede study Participants answer `` yes '' question active suicidal ideation/intent/behaviors occur precede study ( Columbia Suicide Severity Rating Scale , Suicide Ideation section Questions 4 5 ; Suicidal Behavior section ) Female participant pregnant , lactate , want get pregnant study period . Male participant want partner get pregnant Females childbearing potential agree utilize medically acceptable reliable mean birth control study 1 month follow last dose study Participants assess ineligible investigator ( subinvestigator ) reason</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>74 Years</maximum_age>
	<verification_date>January 2015</verification_date>
</DOC>